A year filled with M&A chatter and actions involving Quipt Home Medical (Nasdaq: QIPT) has culminated in the respiratory and home medical equipment provider’s agreement to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management.
Quipt shareholders would receive $3.65 per share in cash, the company said in announcing the agreement on Dec. 15. Quipt described the action as a “special purpose acquisition vehicle” and “an all-cash transaction.”
In May, Quipt reported it had received “an unsolicited, non-binding and conditional and indicative” takeover proposal from Forager Capital Management. At the time, Quipt said Forager was seeking to buy “100% of the company’s issued and outstanding common shares at a price of $3.10 per common share.”
“It is the company’s policy not to comment on unsolicited offers and is confirming its receipt of the non-binding proposal only because Forager has made it public,” Quipt said at the time.
Ultimately, the $3.65 per share price “represents a 162% premium to Quipt’s unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager’s $3.10 per share proposal, and a 54% premium to Quipt’s 30-day VWAP [volume-weighted average price] as of Dec. 12, 2025,” the Dec. 15 announcement said.
Quipt reported the transaction’s value at approximately $260 million, including the company’s existing outstanding debt.
With this acquisition, Quipt becomes a privately held company — though Quipt added that the deal is subject to customary closing conditions.
In September, Quipt announced it had finalized the acquisition of a majority stake in Michigan-based Hart Medical Equipment worth approximately $60 million.
